<DOC>
	<DOCNO>NCT02370030</DOCNO>
	<brief_summary>Triple blind placebo-controlled study determine administer citrulline patient sepsis severe sepsis slow progression multiple organ failure death , measure biomarkers endothelial dysfunction . Patients divide placebo citrulline follow 1 month .</brief_summary>
	<brief_title>Effect Citrulline Clinical Biochemical Evolution Patients With Sepsis .</brief_title>
	<detailed_description>Consecutive patient sepsis recite intensive care unite IMSS CMN Siglo XXI CMN La Raza period november 2015 june 2016 . After sign informed consent randomize 80 intervention arm 80 placebo arm . All patient receive usual medical treatment ; seven day citurlline arm subject receive supplementation oral nasogastric citrulline ( 10 g/day ) , group patient receive seven day oral nasogastric placebo ( 10 g/day ) visible difference . Microalbuminuria interleukines 1 , 6 , 10 measured randomization day 7 . All subject follow 28 day , follow-up period result analyzed determine de efficacy safety citrulline , primary outcome incidence multiple organic failure death , also microalbuminuria level 1,6,10-interleukines . We use Student-t Chi2 statistical analysis .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<criteria>Sepsis Severe sepsis Diagnosis sepsis first 36 hour hospitalization . Informed Consent Intestinal tract intact Terminal cancer Acute chronic liver diseases Chronic renal failure . Acute renal failure AKIN III . Pregnant postpartum woman Dying patient . Patients cardiac arrest . Active gastrointestinal bleeding . Steroids immunosuppressant . Enrolled another study intervention . Citrulline allergy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>sepsis</keyword>
	<keyword>citrulline</keyword>
	<keyword>endothelial</keyword>
	<keyword>toxemia</keyword>
	<keyword>endothelial determination progression</keyword>
	<keyword>v without citrulline</keyword>
</DOC>